Am J Perinatol 2024; 41(07): 902-908
DOI: 10.1055/a-1787-6889
Original Article

Exploration of Differences between Women Who Do and Do Not Disclose Their Marijuana Use during Pregnancy

1   Center for Biobehavioral Health, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio
,
Sarah A. Keim
1   Center for Biobehavioral Health, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio
2   Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio
3   Division of Epidemiology, The Ohio State University College of Public Health, Columbus, Ohio
,
Mark A. Klebanoff
1   Center for Biobehavioral Health, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio
2   Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio
4   Center for Perinatal Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio
5   Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio
› Institutsangaben

Funding The current study was funded by the National Institute on Drug Abuse (NIDA; grant number: R01DA042948); the March of Dimes Foundation (grant no.: 6-FY16-160); and the National Center for Advancing Translational Sciences/National Institutes of Health (grant number: UL1TR001070). The funding sources had no input in the study design; the data collection, interpretation, or analysis; the writing of this report; or the decision to submit the article for publication.
Preview

Abstract

Objective This study aimed to explore demographic and health-related factors that may differentiate women who do and do not disclose their marijuana use during pregnancy.

Study Design The current study is a secondary analysis of data from a prospective cohort of pregnant women identified as using marijuana during pregnancy via a variety of assessment tools including self-report, urine screen, and obstetrics record abstraction. The cohort included a convenience sample of women recruited from several antenatal clinics at The Ohio State University Wexner Medical Center (OSUWMC). To be eligible, women needed to be within the first or second trimester of their pregnancy, 16 to 50 years of age, able to communicate in English, and intended to deliver at OSUWMC. Chi-square, independent samples t-tests, and logistic regression analyses were used to explore differences between those who did and did not disclose their use in relation to physical and mental health diagnoses, adverse experiences, use of other substances, and demographics.

Results Women who used marijuana during their pregnancy and had mental/physical health data available comprised the current sample (n = 109). Women who attended college were more likely to disclose their marijuana use compared with women who did not attend college (p < 0.001). Women who experienced homelessness (p < 0.01) or self-reported alcohol use during pregnancy (p < 0.001) were significantly more likely to disclose their marijuana use.

Conclusion Findings, suggesting disclosure of other substance use and adverse experiences, such as homelessness, may increase the likelihood that pregnant women will voluntarily disclose their marijuana use to providers. Findings did not reflect racial differences nor significant differences in mental/physical health status among women based on their disclosure. Future research with larger datasets is needed to build on these findings by confirming results, as well as exploring additional factors, that may more effectively differentiate women who are unlikely to disclose their prenatal marijuana use from those who do disclose their use.

Key Points

  • Women with higher education were more likely to self-disclose their prenatal marijuana use.

  • Women who experienced homelessness were more likely to self-disclose their prenatal marijuana use.

  • Self-disclosure of prenatal alcohol use was related to self-disclosure of prenatal marijuana use



Publikationsverlauf

Eingereicht: 18. Februar 2021

Angenommen: 18. Februar 2022

Accepted Manuscript online:
03. März 2022

Artikel online veröffentlicht:
12. September 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA